ClinicalTrials.Veeva

Menu

Retrospective Study on Prolonged Sedation Effects With Inhaled Agents in PICU (RESPIRE)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Mechanical Ventilation

Study type

Observational

Funder types

Other

Identifiers

NCT05064592
APHP211236

Details and patient eligibility

About

The objective of the study is to evaluate the effects of halogenated gases on sedation and analgesia, to describe the tolerance and to determine the risk factors for failure, in pediatric intensive care patients during prolonged sedation.

This study will be based on the medical records of patients hospitalized between 2015 and 2020.

Full description

Sedation is a major therapeutic element in patients in intensive care under artificial ventilation, in order to allow their comfort and patient-ventilator synchronization. The use of benzodiazepines in combination with opioids is common practice. However, during prolonged sedation, the effects wane, then the doses must be increased, responsible for an increase in the incidence of a significant withdrawal syndrome in the recovery phase, a source of delay in extubation or early reintubation.

The use of halogenated anesthetic gases is now possible in pediatric intensive care in these patients on artificial ventilation.

Their efficacy and tolerance in prolonged use must be evaluated. Their use could improve the sedative effects, reduce the doses of benzodiazepines and opioids used, and reduce unwanted effects in terms of withdrawal syndrome.

The objective of the study is to evaluate the effects of halogenated gases on sedation and analgesia, to describe the tolerance and to determine the risk factors for failure, in pediatric intensive care patients during prolonged sedation.

This study will be based on the medical records of patients hospitalized between 2015 and 2020.

Enrollment

50 patients

Sex

All

Ages

1 month to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Minor patient over 1 month old (and over 36 WA of corrected age) and under 18 years old
  • Hospitalized in neonatal or pediatric intensive care unit
  • Invasive mechanical ventilation over 72 hours
  • Prolonged sedation greater than 72 hours

Exclusion criteria

- Opposition of the holders of parental authority of the minor patient or the adult patient to the use of the data for the study

Trial design

50 participants in 1 patient group

Patients
Description:
Medical records of minor patients hospitalized between 2015 and 2020 in PICU and having been under sedation and prolonged invasive mechanical ventilation (\> 72h).

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems